Literature DB >> 17541226

Angioimmunoblastic T-cell lymphoma developed with lymphocytic pleural effusion.

Keisuke Hosoki1, Shinji Okada, Ryo Ichinohasama, Masaaki Yamaguchi, Bine Uchiyama, Toshihide Maeyama.   

Abstract

Angioimmunoblastic T-cell lymphoma (AILT) is a rare variant of nodal and aggressive lymphoma. It is sometimes difficult to distinguish AILT from reactive lymphoid hyperplasia from the histopathological aspect. We report a case of AILT which developed with bilateral pleural effusion. The effusion consisted predominately of small lymphoid cells. Analyses of the effusion showed trisomy 3, and rearranged bands of TCR beta gene. Flow cytometry showed a very small amount of CD10-positive cells. Although we could not further identify the tumor cells in this case, analysis of pleural effusion cells will increase our understanding of the pathogenesis and the pathophysiology of AILT.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17541226     DOI: 10.2169/internalmedicine.46.6157

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  3 in total

1.  CD56-positive Angioimmunoblastic T-cell Lymphoma Complicated by Chylothorax.

Authors:  Hiroki Hori; Yasuhiro Tanaka; Ryuko Nakayama; Masaharu Nohgawa
Journal:  Intern Med       Date:  2021-08-31       Impact factor: 1.271

2.  The Early Diagnostic Dilemma in Angioimmunoblastic T Cell Lymphoma with Excessive Plasma Cells Proliferation.

Authors:  Chunyan Wang; Xia Mao; Songya Liu; Cheng He; Ying Wang; Li Zhu; Yangyang Wang; Yicheng Zhang
Journal:  Case Rep Med       Date:  2021-07-16

3.  Cytological features and immunohistochemical findings related to lymphomatous effusion in an angioimmunoblastic T-cell lymphoma patient: Case report.

Authors:  Haruka Furumai; Yoshimasa Nakazato; Hiromi Machida; Hikaru Kato; Tamiko Nagai; Hideo Sasaki; Atsuko Takada-Owada; Yuko Kaneko; Kazuyuki Ishida
Journal:  Diagn Cytopathol       Date:  2021-05-27       Impact factor: 1.582

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.